File:Prequalified pentavalent and years of sales to UNICEF. Figure 5.jpg

From WikiProjectMed
Jump to navigation Jump to search

Prequalified_pentavalent_and_years_of_sales_to_UNICEF._Figure_5.jpg(743 × 297 pixels, file size: 21 KB, MIME type: image/jpeg)

This file is from a shared repository and may be used by other projects. The description on its file description page there is shown below.

Summary

Description
English: Increasing competition in the pentavalent vaccine market; the number of manufacturers making pentavalent vaccine, 2005-2019. From WP:pentavalent vaccine:
Date
Source (18 July 2019). "Shaping markets to benefit global health – A 15-year history and lessons learned from the pentavalent vaccine market". Vaccine: X 2. DOI:10.1016/j.jvacx.2019.100033. PMID 31384748. ISSN 2590-1362.
Author Article authors

Licensing

w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Captions

Add a one-line explanation of what this file represents

Items portrayed in this file

depicts

18 July 2019

image/jpeg

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current03:38, 5 May 2020Thumbnail for version as of 03:38, 5 May 2020743 × 297 (21 KB)commons>HLHJUploaded a work by Article authors from {{cite journal |last1=Malhame |first1=Melissa |last2=Baker |first2=Edward |last3=Gandhi |first3=Gian |last4=Jones |first4=Andrew |last5=Kalpaxis |first5=Philipp |last6=Iqbal |first6=Robyn |last7=Momeni |first7=Yalda |last8=Nguyen |first8=Aurelia |title=Shaping markets to benefit global health – A 15-year history and lessons learned from the pentavalent vaccine market |journal=Vaccine: X |date=18 July 2019 |volume=2 |doi=10.1016/j.jvacx.2019.100033 |pmid...

There are no pages that use this file.